In our previous Bennett Jones insight, we described several upcoming (and far-reaching) amendments to the Competition Act (the Act) introduced by the Government of Canada in 2023. The most recent set of amendments came into...more
Following several years of lively public discussion, two high-profile consultations and the introduction of several “interim amendments” to the Competition Act in 2022, the federal government has now tabled two new bills...more
12/20/2023
/ Acquisitions ,
Antitrust Investigations ,
Antitrust Litigation ,
Antitrust Provisions ,
Canada ,
Competition ,
Competition Act ,
Merger Controls ,
Merger Reviews ,
Mergers ,
New Legislation
On April 26, 2022, the Government of Canada revealed significant proposed amendments to the Competition Act (the Act) as part of the Budget Implementation Act, 2022, No. 1 (the BIA). As expected, these amendments have now...more
On April 26, 2022, the Government of Canada announced proposed amendments to the Competition Act as part of the Budget Implementation Act, 2022. These proposed amendments are likely the first step in the Federal Government's...more
The calls to reform Canada's antitrust framework are growing louder.
On February 7, 2022, the Minister of Innovation, Science and Industry, Francois-Philippe Champagne, announced a comprehensive review of the Competition...more
In the United States and internationally, some unfamiliar questions are being asked about the role of competition policy in the global economy. At the inaugural GCR Live Women in Antitrust conference in Washington, DC, I...more
Canadian public merger and acquisition transactions in 2016 (in-bound and out-bound) comprised over C$400 billion in value with at least one-third of the transactions in Canada being fueled by foreign buyers. The second...more
On June 9, 2015, the Canadian Competition Bureau released updated draft Intellectual Property Enforcement Guidelines (IPEGs) for public comment. The comment period is open until August 10, 2015. It is the third publication of...more
6/15/2015
/ Antitrust Provisions ,
Canada ,
Competition Act ,
Competition Authorities ,
Federal Trade Commission (FTC) ,
Generic Drugs ,
Intellectual Property Protection ,
Patent Assertion Entities ,
Patents ,
Pharmaceutical Industry ,
Standard Essential Patents